wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q40846805-4C7524FA-9D9D-4B9E-8023-A695B776B6C4
Q40846805-4C7524FA-9D9D-4B9E-8023-A695B776B6C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40846805-4C7524FA-9D9D-4B9E-8023-A695B776B6C4
Concurrent sorafenib therapy extends the interval to subsequent TACE for patients with unresectable hepatocellular carcinoma.
P2860
Q40846805-4C7524FA-9D9D-4B9E-8023-A695B776B6C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40846805-4C7524FA-9D9D-4B9E-8023-A695B776B6C4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bdbac4b5ed724e799dd764b7accbc88e20ca1844
P2860
First interim analysis of the GIDEON (Global Investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafeNib) non-interventional study.